Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (21-30 of 409) with videos related to

Pageof 41
Sort By:
The Journal of Biological Chemistry|August 30, 2003
Silencing of CDX2 expression in colon cancer via a dominant repression pathwayTakao Hinoi, Massimo Loda, Eric R Fearon
Idrugs : the Investigational Drugs Journal|April 1, 2009
Novel therapeutic strategies in prostate cancer: establishing a stratification system for patient selection in targeted trialsCarmen Priolo, William K Oh, Massimo Loda
Molecular Cancer Research : MCR|May 10, 2015
Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesGiorgia Zadra, Julie L Batista, Massimo Loda
European Urology|October 17, 2018
Re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7Kathryn L Penney, Massimo Loda, Meir J Stampfer
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 3, 2002
Gene transcript quantitation by real-time RT-PCR in cells selected by immunohistochemistry-laser capture microdissectionNeal Lindeman, David Waltregny, Sabina Signoretti, et al.
Journal of Cellular Biochemistry|December 23, 2003
Fatty acid synthase: a metabolic oncogene in prostate cancer?Antonella Baron, Toshiro Migita, Dan Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2010
New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPKGiorgia Zadra, Carmen Priolo, Akash Patnaik, et al.
Molecular Cancer Research : MCR|January 21, 2021
O-GlcNAc Transferase - An Auxiliary Factor or a Full-blown Oncogene?Harri M Itkonen, Massimo Loda, Ian G Mills
Future Oncology (London, England)|April 9, 2010
Fatty acid synthase as a potential therapeutic target in cancerRichard Flavin, Stephane Peluso, Paul L Nguyen, et al.
The International Journal of Biochemistry & Cell Biology|February 27, 2007
Prostate cancer: Re-focusing on androgen receptor signalingMaria Nieto, Stephen Finn, Massimo Loda, et al.
Pageof 41

Showing results (21-30 of 409) with videos related to

Sort By:
Pageof 41
The Journal of Biological Chemistry|August 30, 2003
Silencing of CDX2 expression in colon cancer via a dominant repression pathwayTakao Hinoi, Massimo Loda, Eric R Fearon
Idrugs : the Investigational Drugs Journal|April 1, 2009
Novel therapeutic strategies in prostate cancer: establishing a stratification system for patient selection in targeted trialsCarmen Priolo, William K Oh, Massimo Loda
Molecular Cancer Research : MCR|May 10, 2015
Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesGiorgia Zadra, Julie L Batista, Massimo Loda
European Urology|October 17, 2018
Re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7Kathryn L Penney, Massimo Loda, Meir J Stampfer
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 3, 2002
Gene transcript quantitation by real-time RT-PCR in cells selected by immunohistochemistry-laser capture microdissectionNeal Lindeman, David Waltregny, Sabina Signoretti, et al.
Journal of Cellular Biochemistry|December 23, 2003
Fatty acid synthase: a metabolic oncogene in prostate cancer?Antonella Baron, Toshiro Migita, Dan Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2010
New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPKGiorgia Zadra, Carmen Priolo, Akash Patnaik, et al.
Molecular Cancer Research : MCR|January 21, 2021
O-GlcNAc Transferase - An Auxiliary Factor or a Full-blown Oncogene?Harri M Itkonen, Massimo Loda, Ian G Mills
Future Oncology (London, England)|April 9, 2010
Fatty acid synthase as a potential therapeutic target in cancerRichard Flavin, Stephane Peluso, Paul L Nguyen, et al.
The International Journal of Biochemistry & Cell Biology|February 27, 2007
Prostate cancer: Re-focusing on androgen receptor signalingMaria Nieto, Stephen Finn, Massimo Loda, et al.
Pageof 41